Stocks / ITC (ITC)

ITC Share Price, Analysis & News

ITC (ITC) — Updated on 2026-05-08

ITC Limited operates within the tobacco industry and is a diversified conglomerate based in India. The company's business segments encompass Fast Moving Consumer Goods (FMCG), Paperboards, Paper and Packaging, and Agri Business. Investors closely monitor the ITC share price to understand its performance and the impact of sector trends on its valuation. The ITC business model integrates these diverse operations, influencing its financial results and overall market position. Analysis of ITC's fundamentals and earnings provides insights into its strategic direction and its ability to navigate the evolving landscape of its operating industries.
Overview Daily Weekly

Key Takeaway

Despite steady revenue growth, flat profits and a significant drawdown suggest underlying business challenges, while sector news offers no immediate company-specific catalyst.

Daily

2026-05-08
  • The stock's short-term outlook remains bearish, with a -3.3% return in the last day and trading below its 50-day EMA and 200-day DMA, suggesting a downward trend is in play.
  • Momentum indicators present a mixed picture: a bullish MACD crossover is observed, but the RSI at 50.82 indicates neutral momentum, implying a lack of strong directional conviction.
  • Fundamentally, the company reported a 6.69% YoY revenue growth to ₹20,047 Cr, but net profit saw only a marginal 0.1% YoY increase, and EPS declined 3.667% QoQ, suggesting some pressure on profitability despite revenue gains.
  • Analyst ratings are predominantly neutral, with 42.857% holding a 'Hold' rating, though a combined 37.143% recommend 'Buy' or 'Strong Buy', indicating a divided expert opinion that has remained stable.
  • Ownership patterns show DIIs holding the largest stake at 49.15%, but overall institutional holdings decreased by 1.03% QoQ, with FIIs reducing their stake, while public shareholding saw a slight increase of 1.01%.
Open daily analysis

Weekly

Latest weekly signal
  • The stock price declined 2.41% this week, closing at 307.3 as trading volume increased by 22.9% compared to the previous week.
  • Technical momentum has cooled, with the Relative Strength Index (RSI, a measure of price speed and change) dropping to 50.82 from 60.83.
  • The NCLT sanctioned the amalgamation of Sresta Natural Bioproducts and Wimco Limited with ITC, which becomes effective on June 1, 2026.
  • CRISIL Ratings reaffirmed the company's AAA/Stable/A1+ ratings, citing a robust business risk profile and strong liquidity.
  • The company maintains a valuation of 19.1x PE (Price-to-Earnings ratio, comparing share price to per-share earnings) and 5.6x PB (Price-to-Book ratio, comparing market value to book value).
Open weekly analysis

Quarterly

Latest quarterly update
Detailed analysis available on the full page.

Price & Technical Structure

  • Short-term returns show a negative trend with a 1-day return of -3.3% and a 3-month return of -2.35%.
  • The stock is trading below its 50-day EMA (310.67) and 200-day DMA (-13.44% distance), indicating a bearish trend alignment.
  • Momentum indicators are mixed, with a bullish MACD crossover but an RSI of 50.82, suggesting neutral momentum.
  • Volatility is moderate, with the price positioned at 54.94% of the Bollinger Band width, and an annualized volatility of 19.63%.
  • The stock is trading 30.57% below its 52-week high and has experienced a current drawdown of -30.57%.
The stock exhibits a bearish short-term trend, evidenced by its position below key EMAs and DMAs. Momentum is neutral to slightly bullish, with a MACD crossover but an RSI around the midpoint. Volatility remains within moderate levels, and the stock is significantly off its 52-week high, indicating substantial downside from its peak. The current technical setup suggests caution, with no strong conviction from volume signals to counter the prevailing bearish trend.

Weekly Momentum

  • The stock price declined 2.41% this week, closing at 307.3 as trading volume increased by 22.9% compared to the previous week.
  • Technical momentum has cooled, with the Relative Strength Index (RSI, a measure of price speed and change) dropping to 50.82 from 60.83.
  • The NCLT sanctioned the amalgamation of Sresta Natural Bioproducts and Wimco Limited with ITC, which becomes effective on June 1, 2026.
  • CRISIL Ratings reaffirmed the company's AAA/Stable/A1+ ratings, citing a robust business risk profile and strong liquidity.
  • The company maintains a valuation of 19.1x PE (Price-to-Earnings ratio, comparing share price to per-share earnings) and 5.6x PB (Price-to-Book ratio, comparing market value to book value).
ITC experienced a week of downward price pressure, with the stock closing at 307.3, remaining below both its 20-day and 50-day moving averages. This bearish alignment is accompanied by a contraction in volatility and a decline in momentum indicators, suggesting a period of consolidation within a broader downward trend. Despite the price decline, the company continues to operate with a stable financial profile, as evidenced by the reaffirmation of its AAA credit rating and the successful NCLT approval for the merger of Sresta and Wimco. Market participants are currently balancing these structural developments against the ongoing competitive environment in the FMCG sector.